{"name":"Convergence Pharmaceuticals","permalink":"convergence-pharmaceuticals","crunchbase_url":"http://www.crunchbase.com/company/convergence-pharmaceuticals","homepage_url":"http://www.convergencepharma.com/","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"info@convergencepharma.com","phone_number":"+44 (0)1223 755 501","description":"","created_at":"Fri Oct 08 03:51:29 UTC 2010","updated_at":"Fri Oct 08 03:51:28 UTC 2010","overview":"<p>Convergence Pharmaceuticals is an independent biotechnology company focused on the development of novel analgesics with potentially commercially attractive efficacy, responder-rate and side effect profiles. The Company was formed in October 2010 following the acquisition of certain neuroscience clinical assets from GlaxoSmithKline (â€œGSKâ€). Convergence Pharmaceuticals has a pipeline of differentiated clinical-stage compounds targeting the points of convergence in chronic pain signaling through modulation of specific ion-channels.</p>","image":{"available_sizes":[[[150,31],"assets/images/resized/0010/4669/104669v1-max-150x150.png"],[[250,51],"assets/images/resized/0010/4669/104669v1-max-250x250.png"],[[385,80],"assets/images/resized/0010/4669/104669v1-max-450x450.png"]],"attribution":null},"products":[],"relationships":[{"is_past":false,"title":"CEO","person":{"first_name":"Clive","last_name":"Dix","permalink":"clive-dix","image":null}},{"is_past":false,"title":"COO","person":{"first_name":"Brenda","last_name":"Reynolds","permalink":"brenda-reynolds","image":null}}],"competitions":[],"providerships":[],"total_money_raised":"$35.4M","funding_rounds":[{"round_code":"a","source_url":"http://www.finsmes.com/2010/10/convergence-pharmaceuticals-raises-354m.html","source_description":"Convergence Pharmaceuticals Raises $35.4M in Series A Financing","raised_amount":35400000,"raised_currency_code":"USD","funded_year":2010,"funded_month":10,"funded_day":5,"investments":[{"company":null,"financial_org":{"name":"New Leaf Venture Partners","permalink":"new-leaf-venture-partners-2","image":{"available_sizes":[[[150,39],"assets/images/resized/0004/2730/42730v1-max-150x150.png"],[[250,66],"assets/images/resized/0004/2730/42730v1-max-250x250.png"],[[257,68],"assets/images/resized/0004/2730/42730v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Apposite Capital","permalink":"apposite-capital","image":{"available_sizes":[[[150,16],"assets/images/resized/0004/8877/48877v1-max-150x150.jpg"],[[250,28],"assets/images/resized/0004/8877/48877v1-max-250x250.jpg"],[[450,50],"assets/images/resized/0004/8877/48877v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"SV Life Sciences","permalink":"sv-life-sciences","image":{"available_sizes":[[[150,70],"assets/images/resized/0004/5361/45361v1-max-150x150.jpg"],[[250,117],"assets/images/resized/0004/5361/45361v1-max-250x250.jpg"],[[267,125],"assets/images/resized/0004/5361/45361v1-max-450x450.jpg"]],"attribution":null}},"person":null}]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"","address1":"Maia Building","address2":"Babraham Research Campus","zip_code":"CB22 3AT","city":"Cambridge ","state_code":null,"country_code":"GBR","latitude":null,"longitude":null}],"milestones":[],"ipo":null,"video_embeds":[],"screenshots":[],"external_links":[]}